BSE Prices delayed by 5 minutes... << Prices as on Oct 31, 2025 >>   ABB  5214.8 ATS - Market Arrow  [-1.15]  ACC  1881.3 ATS - Market Arrow  [1.20]  AMBUJA CEM  565.25 ATS - Market Arrow  [-0.52]  ASIAN PAINTS  2510 ATS - Market Arrow  [-0.55]  AXIS BANK  1233 ATS - Market Arrow  [-0.45]  BAJAJ AUTO  8893.9 ATS - Market Arrow  [-0.33]  BANKOFBARODA  278.3 ATS - Market Arrow  [2.05]  BHARTI AIRTE  2054.6 ATS - Market Arrow  [-0.56]  BHEL  266.25 ATS - Market Arrow  [1.91]  BPCL  356.8 ATS - Market Arrow  [-0.24]  BRITANIAINDS  5840.5 ATS - Market Arrow  [-0.26]  CIPLA  1501.65 ATS - Market Arrow  [-2.52]  COAL INDIA  388.7 ATS - Market Arrow  [0.25]  COLGATEPALMO  2244.2 ATS - Market Arrow  [-0.46]  DABUR INDIA  487.9 ATS - Market Arrow  [-2.68]  DLF  756.2 ATS - Market Arrow  [-2.64]  DRREDDYSLAB  1197.75 ATS - Market Arrow  [-0.37]  GAIL  182.8 ATS - Market Arrow  [-0.16]  GRASIM INDS  2893.2 ATS - Market Arrow  [-1.98]  HCLTECHNOLOG  1541.4 ATS - Market Arrow  [-0.54]  HDFC BANK  987.65 ATS - Market Arrow  [-1.05]  HEROMOTOCORP  5544.8 ATS - Market Arrow  [0.55]  HIND.UNILEV  2466.65 ATS - Market Arrow  [-0.12]  HINDALCO  847.7 ATS - Market Arrow  [-1.62]  ICICI BANK  1345.05 ATS - Market Arrow  [-1.28]  INDIANHOTELS  742.15 ATS - Market Arrow  [-1.01]  INDUSINDBANK  794.1 ATS - Market Arrow  [-0.97]  INFOSYS  1482.5 ATS - Market Arrow  [-0.74]  ITC LTD  420.25 ATS - Market Arrow  [0.37]  JINDALSTLPOW  1066.7 ATS - Market Arrow  [-0.25]  KOTAK BANK  2101.95 ATS - Market Arrow  [-1.66]  L&T  4031.2 ATS - Market Arrow  [1.09]  LUPIN  1964.25 ATS - Market Arrow  [0.98]  MAH&MAH  3486.35 ATS - Market Arrow  [-0.42]  MARUTI SUZUK  16191.9 ATS - Market Arrow  [-0.08]  MTNL  41.7 ATS - Market Arrow  [-0.64]  NESTLE  1271.55 ATS - Market Arrow  [-0.66]  NIIT  104.35 ATS - Market Arrow  [-0.52]  NMDC  75.78 ATS - Market Arrow  [-0.17]  NTPC  336.85 ATS - Market Arrow  [-2.39]  ONGC  255.45 ATS - Market Arrow  [0.39]  PNB  122.9 ATS - Market Arrow  [2.33]  POWER GRID  288.15 ATS - Market Arrow  [-1.17]  RIL  1486.5 ATS - Market Arrow  [-0.13]  SBI  937 ATS - Market Arrow  [0.31]  SESA GOA  493.6 ATS - Market Arrow  [-2.62]  SHIPPINGCORP  259.6 ATS - Market Arrow  [-1.69]  SUNPHRMINDS  1689.85 ATS - Market Arrow  [-0.81]  TATA CHEM  890.75 ATS - Market Arrow  [-1.10]  TATA GLOBAL  1165.1 ATS - Market Arrow  [-1.01]  TATA MOTORS  410.1 ATS - Market Arrow  [-0.53]  TATA STEEL  182.95 ATS - Market Arrow  [-0.76]  TATAPOWERCOM  405.05 ATS - Market Arrow  [-1.12]  TCS  3057.8 ATS - Market Arrow  [0.73]  TECH MAHINDR  1424.8 ATS - Market Arrow  [-0.61]  ULTRATECHCEM  11946.8 ATS - Market Arrow  [-0.87]  UNITED SPIRI  1430.8 ATS - Market Arrow  [2.71]  WIPRO  240.65 ATS - Market Arrow  [-0.50]  ZEETELEFILMS  100.65 ATS - Market Arrow  [-1.23]  

Thyrocare Technologies Ltd.

Notes to Accounts

NSE: THYROCAREEQ BSE: 539871ISIN: INE594H01019INDUSTRY: Hospitals & Medical Services

BSE   Rs 1396.60   Open: 1340.65   Today's Range 1330.55
1402.10
 
NSE
Rs 1397.30
+50.00 (+ 3.58 %)
+47.75 (+ 3.42 %) Prev Close: 1348.85 52 Week Range 658.00
1470.00
You can view the entire text of Notes to accounts of the company for the latest year
Market Cap. (Rs.) 7413.22 Cr. P/BV 15.18 Book Value (Rs.) 92.03
52 Week High/Low (Rs.) 1474/658 FV/ML 10/1 P/E(X) 81.01
Bookclosure 24/10/2025 EPS (Rs.) 17.25 Div Yield (%) 1.50
Year End :2025-03 

M. Provisions, Contingent Liabilities and Contingent
Assets

A provision is recognized when the enterprise has a
present obligation (legal or constructive) as a result
of a past event and it is probable that an outflow of
resources embodying economic benefits will be
required to settle the obligation, in respect of which
a reliable estimate can be made. These are reviewed
at each balance sheet date and adjusted to reflect the
current management estimates.

If the effect of the time value of money is material,
provisions are determined by discounting the expected
future cash flows specific to the liability. The unwinding
of the discount is recognized as finance cost.

Contingent Liabilities are disclosed in respect of
possible obligations that arise from past events but
their existence is confirmed by the occurrence or non¬
occurrence of one or more uncertain future events not
wholly within the control of the Company.

A contingent asset is a possible asset that arises from
past events and whose existence will be confirmed only
by the occurrence or non-occurrence of one or more
uncertain future events not wholly within the control of
the entity. Contingent Assets are not recognized till the
realization of the income is virtually certain. However,
the same are disclosed in the financial statements
where an inflow of economic benefit is probable.

N. Revenue from Operations

Revenue includes the gross inflows of economic benefits. It is measured based on the consideration specified in the
contracts with customers. Amounts collected on behalf of third parties such as goods and services taxes are not economic
benefits which flow to the entity and do not result in increases in equity. Therefore, they are excluded from revenue.

Ind AS 115 establishes a comprehensive framework for determining whether, how much and when revenue is recognized.
Under Ind AS 115, revenue is recognised when a customer obtains control of the goods or services. Determining the
timing of the transfer of control - at a point in time or over a period of time requires judgement and facts / circumstances
of transaction / income.

Contract liabilities

A contract liability is the obligation to provides services
to a customer for which the Company has received
consideration from the customer. If a customer pays
consideration before the Company provides services
to the customer, a contract liability is recognised
when the payment is made. Contract liabilities are
recognised as revenue when the Company performs
under the contract.

O. Leases
Identifying leases

The Company accounts for a contract, or a portion
of a contract, as a lease when it conveys the right
to use an asset for a period of time in exchange for
consideration. Leases are those contracts that satisfy
the following criteria:

(i) There is an identified asset;

(ii) The Company obtains substantially all the
economic benefits from use of the asset; and

(iii) The Company has the right to direct
use of the asset.

The Company considers whether the supplier has
substantive substitution rights. If the supplier does
have those rights, the contract is not identified as
giving rise to a lease.

In determining whether the Company obtains
substantially all the economic benefits from use of
the asset, the Company considers only the economic
benefits that arise from use of the asset, not those
incidentals to legal ownership or other potential benefits.

In determining whether the Company has the right to
direct use of the asset, the Company considers whether
it directs how and for what purpose the asset is used
throughout the period of use. If there are no significant
decisions to be made because they are pre-determined
due to the nature of the asset, the Company considers
whether it was involved in the design of the asset in a
way that predetermines how and for what purpose the
asset will be used throughout the period of use. If the
contract or portion of a contract does not satisfy these
criteria, the Company applies other applicable Ind AS
rather than Ind AS 116.

P. Recognition of rental income, dividend income,
interest income or expense

Rental income is recognised as part of other income
in the Statement of Profit and Loss on a straight-line
basis over the term of the lease except where the

rentals are structured to increase in line with expected
general inflation.

Dividend income is recognised in profit or loss on the
date on which the Company's right to receive payment
is established.

Interest income or expense is recognised using the
effective interest method.

The 'effective interest rate' is the rate that exactly
discounts estimated future cash payments or receipts
through the expected life of the financial instrument to:

- the gross carrying amount of the financial asset; or

- the amortised cost of the financial liability.

Q. Income tax

Tax expense recognised in Statement of Profit and
Loss comprises the sum of deferred tax and current
tax. It is recognised in the Statement of Profit and Loss,
except when it relates to an item that is recognised in
OCI or directly in equity, in which case, the tax is also
recognised in OCI or directly in equity.

(i) Current tax

Current tax comprises the expected tax payable
or refund receivable on the taxable income or loss
for the year and any adjustment to the tax payable
or receivable in respect of previous years. The
amount of current tax reflects the best estimate
of the tax amount expected to be paid or refund
receivable after considering the uncertainty, if
any, related to income taxes. It is measured using
tax rates (and tax laws) enacted or substantively
enacted by the reporting date.

Current tax assets and current tax liabilities are
offset only if there is a legally enforceable right to
set off the recognised amounts, and it is intended
to realise the asset and settle the liability on a net
basis or simultaneously.

(ii) Deferred tax

Deferred tax is recognised in respect of temporary
differences between the carrying amounts
of assets and liabilities for financial reporting
purposes and the corresponding amounts used
for taxation purposes.

Deferred tax assets are recognised to the
extent that it is probable that future taxable
profits will be available against which they can
be used. Deferred tax assets - unrecognised or
recognised, are reviewed at each reporting date

and are recognised/ reduced to the extent that it
is probable/ no longer probable respectively that
the related tax benefit will be realised.

Deferred tax is measured at the tax rates that are
expected to apply to the period when the asset
is realised or the liability is settled, based on the
laws that have been enacted or substantively
enacted by the reporting date.

R. Events occurring after the Balance Sheet Date

Where events occurring after the balance sheet date
provide evidence of conditions that existed at the end
of the reporting period, the impact of such events is
adjusted within the Financial Statements. Otherwise,
events after the balance sheet date of material size or
nature are only disclosed.

S. Earning Per share

Basic earnings per equity share is computed by
dividing the net profit attributable to the equity holders
of the Company by the weighted average numbers of
the equity shares outstanding during the period. The
weighted average number of equity shares outstanding
during the period is adjusted for events such as bonus
issue, bonus element in a rights issue, share split, and
reverse share split (consolidation of shares) that have
changed the number of equity shares outstanding,
without a corresponding change in resources.

For the purpose of calculating diluted earnings per
share, the net profit or loss for the period attributable
to equity shareholders of the Company and the
weighted average number of shares outstanding
during the period are adjusted for the effects of all
dilutive potential equity shares.

Diluted earnings per equity share is computed by
dividing the net profit attributable to the equity holders
of the Company by the weighted average number of
equity shares considered for deriving basic earnings
per equity share and the weighted average number
of equity shares that would have been outstanding
assuming the conversion of all dilutive potential equity

shares. The dilutive potential equity shares are adjusted
for the proceeds receivable had the equity shares
been actually issued at fair value (i.e. the average
market value of the outstanding equity shares). Dilutive
potential equity shares are deemed converted as of
the beginning of the period, unless issued at a later
date. Dilutive potential equity shares are determined
independently for each period presented.

T. Cash flow statement

Cash flows are reported using the indirect method,
whereby profit for the period is adjusted for the effects
of transactions of non-cash nature, any deferrals or
accruals of past or future operating cash receipts or
payments and item of income or expenses associated
with investing or financing cash flows. The Company
segregate the cash flows in operating, investing and
financing activities.

U. Segment reporting

In accordance with Ind AS 108 'Operating Segments',
segment information has been given in the consolidated
financial statements of the holding company.

V. Investment in subsidiaries, associates and joint
ventures

Investments in subsidiaries, associates and joint
ventures are measured at cost as per Ind AS 27 -
Separate Financial Statements less accumulated
impairment, if any as per Ind AS 36 Impairment of Assets.

W. Recent Accounting Standards and
Pronouncements

Ministry of Corporate Affairs ("MCA") notifies new
standards or amendments to the existing standards
under Companies (Indian Accounting Standards) Rules
as issued from time to time. For the year ended March
31, 2025, MCA has notified Ind AS - 117 Insurance
Contracts and amendments to Ind AS 116 - Leases,
relating to sale and leaseback transactions, applicable
to the Company w.e.f. April 1, 2024. The Company has
reviewed the new pronouncements and based on its
evaluation has determined that it does not have any
significant impact in its financial statements.

Measurement of fair values

The Company has sub-let part of the leasehold land and constructed building thereon, to its subsidiary for business
operations after getting an approval from the lessor. Since the premises is constructed on leasehold plot of land, the sub-let
part of the premises is not saleable independently. The fair value of the investment property would be difficult to determine
reliably. The premises is constructed on industrial leasehold plot of land and there are very few recent transactions. In case
of the previously observed transaction for transfer of plot prices, the variations in the prices indicate that the transfer price is
not indicative of market prices. Also, the alternative reliable measurement of fair value are not available due to the regulatory
restrictions as to usage, transfer, leasing and subletting of the property within the jurisdiction.

Equity Contribution by the Ultimate Holding Company reserve

API Holdings Limited (the 'Ultimate Holding Company') has established various equity-settled share-based payment plans
for certain categories of employees of the Company. The respective employees are entitled to equity shares of the Ultimate
Holding Company on exercising of options granted to them after completion of the vesting period, as per the plans. The
Ultimate Holding Company is not charging any consideration towards reimbursement of the grant of options from the
Company. The balance in the Equity Contribution by Ultimate Holding Company Reserve account represents the expenses
recorded pursuant to the aforesaid schemes for which the options are not yet vested or exercised, as the same is considered
as equity contribution by the Ultimate Holding Company. (Refer note 36 for further details on these plans).

General Reserve

General Reserve is used to record the transfer from retained earnings of the Company.

Capital Redemption Reserve

The Company bought back 9,58,900 equity shares for an aggregate amount of H 63.00 crores being 1.78% of the total paid
up equity share capital, at an average price of H 656.90 per equity share. The equity shares bought back were extinguished
on 12 October 2018 and 22 October 2018 and as per the provisions of the Companies Act, 2013, the Capital Redemption
Reserve is used to record the reduction of the share capital of the Company on account of equity shares bought back out of
the accumulated profits. It is created in accordance with the provisions of the Companies Act, 2013.

Retained Earnings

Retained Earnings represents the accumulated profits carried forward after adjusting for the appropriations as at the
end of the year.

35. Employee benefits

A. Defined contribution plans

i. The Company makes Provident Fund, ESIC and Maharashtra Labour Welfare Fund contributions to defined
contribution plans for qualifying employees. Under the Schemes, the Company is required to contribute a specified
percentage of the payroll costs to fund the benefits. Amount for the year ended 31 March 2025 of H 4.87 crores
(31 March 2024 : H 4.58 Crores) is recognised as expense and included in Employee benefit expenses. The
contributions payable to these plans by the Company are at rates specified in the rules of the schemes. The
Company does not expect any further liability other than the specified contributions. (Refer note 29)

ii. The Company will continue to assess the impact of further developments relating to retrospective application of
Supreme Court judgement dated February 28, 2019 clarifying the definition of 'basic wages' under Employees'
Provident Fund and Miscellaneous Provisions Act 1952 and deal with it accordingly. In the assessment of the
management, the aforesaid matter is not likely to have a significant impact and accordingly, no provision has been
made in the Standalone Financial Statements.

Furthermore, in presenting the above sensitivity analysis, the present value of the Defined Benefit Obligation has
been calculated using the projected unit credit method at the end of the reporting period, which is the same
method as applied in calculating the Defined Benefit Obligation as recognised in the balance sheet.

There was no change in the methods and assumptions used in preparing the sensitivity analysis from prior years.

36. Share-based payments

A. Description of share-based payment arrangements

The shareholders of the Company had approved the Thyrocare Employees Stock Option Scheme ("ESOS/ Scheme") in
the Annual General Meeting ("AGM") held on September 26, 2015, which was subsequently modified in the AGM held
on August 10, 2023. Pursuant to the said modification, the shareholders authorized the Board of Directors and/or the
Nomination and Remuneration Committee to grant stock options to eligible employees until all remaining options under
the ESOS are exhausted and the equivalent number of equity shares are issued and allotted.

Further, by way of special resolution passed through postal ballot (Notice dated October 23, 2024) on January 09,
2025, the shareholders approved the extension of ESOS to eligible employees of the Holding and/or Subsidiary
Company(ies) of Thyrocare.

B. Description of share-based payment arrangements by the Ultimate Holding Company

During the year, API Holdings Limited (the Ultimate Holding Company) has offered equity-settled share-based payment
plans for certain categories of employees of the Company. Also certain eligible employees of the Ultimate Holding
Company transferred on the payroll of Thyrocare Tecnologies Limited (the Company). The respective employees are
entitled to equity shares of the Ultimate Holding Company on exercising of options granted to them after completion of
their respective vesting period. The Ultimate Holding Company is not charging any consideration towards reimbursement
of the grant of options from the Company.

B. Measurement of fair values

The Management assessed that cash and bank balances, trade receivables, trade payables and other financial assets
and liabilities approximate their carrying amounts largely due to short-term maturities of these instruments.

The fair value of investment in mutual funds is included at the amount at which the instruments could be exchanged
in a current transaction between willing parties, other than in a forced or liquidation sale. The fair value of the
quoted investments/units of mutual fund scheme are based on net asset value at the reporting date as published by
the mutual fund.

Fair value of financial assets and liabilities measured at amortised cost is not materially different from the amortised cost.
Further, impact of time value of money is not significant for the financial instruments classified as current. Accordingly,
the fair value has not been disclosed separately.

C. Financial risk management

The Company's Board of Directors has overall responsibility for the establishment and oversight of the Company's risk
management framework. The Board of Directors has established a Risk Management Committee, which is responsible
for developing and monitoring the Company's risk management policies. The committee reports regularly to the Board
of Directors on its activities.

The Company's risk management policies are established to identify and analyse the risks faced by the Company, to
set appropriate risk limits and controls and to monitor risks and adherence to limits. Risk management policies and
systems are reviewed regularly to reflect changes in market conditions and the Company's activities. The Company,
through its training and management standards and procedures, aims to maintain a disciplined and constructive control
environment in which all employees understand their roles and obligations.

The Company's audit committee oversees how management monitors compliance with the Company's risk management
policies and procedures, and reviews the adequacy of the risk management framework in relation the risks faced by
the Company. The audit committee is assisted in its oversight role by internal audit. Internal audit undertakes both
regular and ad hoc reviews of risk management controls and procedures, the results of which are reported to the
audit committee.

The Company has exposure to the following risks arising from financial instruments:

i. Credit risk

ii. Liquidity risk

iii. Market risk

i. Credit risk

Credit risk is the risk of financial loss to the Company if a customer or a counterparty to a financial instrument fails
to meet its contractual obligations, and arises principally from the Company's trade and other receivables . The
carrying amounts of financial assets represent the maximum credit risk exposure.

a) Trade and Other Receivables

Trade receivables are typically unsecured and are derived from revenue earned from customers located in
India. Credit risk has always been managed by the Company through credit approvals, establishing credit
limits and continuously monitoring the creditworthiness of customers to which the Company grants credit
terms in the normal course of business.

The Company uses Expected Credit Loss model to assess the impairment loss. The Company computes the
expected credit loss allowance as per simplified approach for trade receivables based on available external
and internal credit risk factors such as the ageing of its dues, market information about the customer and the
company's historical experience for customers.

b) Loans and financial assets measured at amortized cost

Loans and advances given comprises inter company loans hence the risk of default from these companies is
remote. The Company monitors each loans given and makes any specific provision if required.

c) Cash and cash equivalents and Bank balances other than cash and cash equivalents

The Company held cash and cash equivalent and Bank balances other than cash and cash equivalents of
H 51.98 crores as at 31 March 2025 (31 March 2024 : H 34.10 crores). The same are held with banks. Also,
Company invests its short term surplus funds in bank fixed deposit which carry no market risks for short
duration, therefore does not expose the company to credit risk.

d) Others

Apart from trade receivables, loans and cash and bank balances, the Company has no other financial assets
which carry any significant credit risk.

ii. Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its
financial liabilities that are settled by delivering cash or another financial assets. The Company's approach to
managing liquidity is to ensure, as far as possible, that it will have sufficient liquidity to meet its liabilities when they
are due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to
the Company's reputation.

Exposure to liquidity risk

The following are remaining contractual maturities of financial liabilities at the reporting date. The amounts are
gross and undiscounted, and include contractual interest payments and exclude the impact of netting agreements.

iii. Market risk

Market risk is the risk that changes in market prices - such as foreign exchange rates, interest rates and equity
prices - will affect the Company's income or the value of its holdings of financial instruments. The objective of
market risk management is to manage and control market risk exposures within acceptable parameters, while
optimizing the return.

Currency risk

The Company is exposed to currency risk to the extent that there is a mismatch between the currencies in which
sales and purchases are denominated and the functional currency of Company. The functional currency for large
number of transactions of the Company is Rs. and majority of the customers the Company dealt with operate from
India only. The Company receives almost all of its revenue from the domestic operations.

Exposure to currency risk

The summary quantitative data about the Company's exposure to currency risk as reported to the
management is as follows.

Sensitivity analysis

A reasonably possible strengthening (weakening) of the INR or US dollar at 31 March 2025 would have affected the
measurement of financial instruments denominated in foreign currency and affected equity and profit or loss by the
amounts shown below. This analysis assumes that all other variables, in particular interest rates, remain constant
and ignores any impact of forecast sales and purchases.

The Company has entered into Reagent Rental Arrangements for periods ranging from 2 - 7 years with some of its major reagent
suppliers. As per the terms of the agreement, these reagent suppliers have placed the analysers / diagnostic equipments
at no cost in the processing laboratory. The analysers / diagnostic equipments are programmed by the manufacturers to
be used only against the reagent supplier's brand of reagent kits. The commitments as per these arrangements are either
purchase commitments or rate commitments based on the workloads. The value of purchase commitments for the next
financial year is H 85.71 crores (31 March 2024 : H 84.47 crores) as per the terms of these arrangements.

Notes :

During the reporting period, the company conducted transactions with these related parties in the ordinary course
of business. The transactions with related parties are made on terms equivalent to those that prevail in arm's length
transactions. Outstanding balances at the year-end are unsecured and settlement occurs in cash.

40. Additional information to the financial statements
a. Segment reporting

The Company is primarily engaged in the business of diagnostic services, which as per Ind AS 108 on 'Operating
Segments', constitutes a single reporting business segment.

There are no material individual markets outside India and hence it has not disclosed information for geographical
segments with respect to the segment revenues or results or assets. During the year ended 31 March 2025 and 31
March 2024, revenue from transactions with a single external customer did not amount to 10 percent or more of the
Company's revenues from the external customers.

b. During the current year, the Company has made two business acquisitions in the diagnostic services sector. On 2
July 2024, the Company signed a Business Transfer Agreement (BTA) with Polo Labs Private Limited to acquire its
diagnostic services business for a purchase consideration of H 4.26 Crores. The acquisition was recorded with H 1.22
Crores recognized as Goodwill, H 0.80 Crores for Brand name, H 0.69 Crores for Non-compete fees, H 0.45 for Software
and H 1.10 Crores for net Fixed assets.

Subsequently, on 11 October 2024, the Company completed the acquisition of the business of diagnostic services
of Vimta Labs Limited's for a purchase consideration of H 7 Crores. The acquisition was recorded with H 2.96 Crores
recognized as Goodwill, H 2.34 Crores for Customer relationships, H 0.31 Crores for Non-compete fees and H 1.39 Crores
for net fixed assets.

d. Capital Management

For the purpose of the Company's capital management, capital includes issued equity capital and all other equity
reserves attributable to the equity holders of the Company. The primary objective of the Company's capital management
is to safeguard the Company's ability to remain as a going concern and maximise the shareholder value. The current
capital structure of the Company is equity based with financing through borrowings. The Company is not subject to any
externally imposed capital requirement. No changes were made in the objectives, policies or processes for managing
capital during the year ended 31 March 2025 and 31 March 2024. The net debt to equity ratio for the current year has
decreased as a result of the borrowings repaid fully during the current year.

f. The Indian Parliament has approved the Code on Social Security, 2020 which would impact the contributions by the
Company towards Provident Fund and Gratuity. The Ministry of Labour and Employment has released draft rules for the
Code on Social Security, 2020 on November 13, 2020, and has invited suggestions from stakeholders which are under
active consideration by the Ministry. The Company will assess the impact and its evaluation once the subject rules are
notified and will give appropriate impact in its financial statements in the period in which, the Code becomes effective
and the related rules to determine the financial impact are published.

g. Other Statutory Information:

(i) Details of benami property held

No proceedings have been initiated or are pending against the Company for holding any benami property under the
Benami Transactions (Prohibitions) Act, 1988 and the rules made thereunder.

(ii) Relationships with struck off companies

The Company does not have any relationship with companies struck off under Section 248 of the Companies Act,
2013 or Section 560 of the Companies Act, 1956.

(iii) Registration of charges or satisfaction with Registrar of Companies

The Company does not have any charges or satisfaction which is yet to be registered with ROC beyond the
statutory period.

(iv) Details of crypto currency or virtual currency

The Company has not traded or invested in Crypto currency or Virtual Currency during the current or previous year.

(v) Utilisation of borrowings availed from banks and financial institutions

The Company has not advanced or extended loan or invested funds to any other person(s) or entity(ies), including
foreign entities (Intermediaries) with the understanding that the Intermediary shall:

(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on
behalf of the company (Ultimate Beneficiaries) or

(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.

The Company have not received any fund from any person(s) or entity(ies), including foreign entities (Funding
Party) with the understanding (whether recorded in writing or otherwise) that the Company shall:

(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on
behalf of the Funding Party (Ultimate Beneficiaries) or

(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.

(vi) Undisclosed Income

The Company does not have any undisclosed income which is not recorded in the books of account that has been
surrendered or disclosed as income during the year (previous year) in the tax assessments under the Income Tax
Act, 1961 (such as, search or survey or any other relevant provisions of the Income Tax Act, 1961.

(vii) Wilful defaulter

The Company has not been declared wilful defaulter by any bank or financial institution or by any other lender.

(viii) Compliance with number of layers of companies

The company has complied with the number of layers prescribed under clause (87) of section 2 of the Act read with
the Companies (Restriction on number of Layers) Rules, 2017.

(ix) Compliance with approved scheme(s) of arrangements

The company has not entered into any scheme of arrangement which has an accounting impact on current or
previous financial year.

(x) Title deeds of immovable properties not held in name of the company

The title deeds of all the immovable properties (other than properties where the company is the lessee and the
lease arrangements are duly executed in favour of the lessee) are held in the name of the Company during the
current and previous year.

(xi) Valuation of PPE, intangible assets and Investment property

The company has not revalued its property, plant and equipment (Including Right of use assets) or intangible
assets during the current or previous year.

(xii) Audit trail:

The Ministry of Corporate Affairs (MCA) has prescribed a requirement for companies under the proviso to Rule 3(1)
of the Companies (Accounts) Rules, 2014 inserted by the Companies (Accounts) Amendment Rules 2021. The said
proviso requires companies, which uses accounting software for maintaining its books of accounts, to use only
such accounting software which has a feature of recording audit trail of each and every transaction, creating an
edit log of each change made in the books of accounts along with the dates when such changes were made and
ensuring that the audit trail cannot be disabled.

During the year ended 31 March 2025 with respect to one software which has a feature of recording audit trail
(edit log) facility and the same has been enabled and operated throughout the year for all relevant transactions
recorded in the accounting software. Further, there were no instances of the audit trail feature being tampered
with. Additionally, the audit trail of prior year has been preserved by the Company as per the statutory requirements
for record retention.

Another software had a feature of recording audit trail (edit log) facility at the database level only and the same
has been enabled and operated from October 2024 till March 2025 for all relevant transactions recorded in the
accounting software.

Further, there were no instances of the audit trail feature being tampered with. Additionally, the audit trail of prior
year has been preserved as per the statutory requirements for record retention to the extent it was enabled and
recorded in respective year.

Further, for the two other accounting softwares and one software (at application level) used for maintaining its
books of account during the year ended 31 March 2025 did not have a feature of recording audit trail (edit log)
facility throughout the year. The management is in the process of evaluating the options / enabling the edit log
facility for these softwares.

(xiii) Back up of books of account:

The company uses software applications to maintain its books of accounts and other books and papers in electronic
mode ("Electronic records"). During the year, the Company has maintained backups of these electronic records on
server physically located in India on daily basis, as required by Companies (Accounts) Rules, 2014 (as amended).

(xiv) Borrowings secured against current assets

The Company does not have borrowings from banks or financial institutions on the basis of security of current assets.

h. The figures of the previous year have been regrouped wherever necessary to correspond with the current year's
classification / disclosures.

As per our report of even date attached

For M S K A & Associates For and on behalf of the Board of Directors of

Chartered Accountants Thyrocare Technologies Limited

Firm's Registration No: 105047W CIN - L85110MH2000PLC123882

Ojas D. Joshi Dharmil Sheth Rahul Guha

Partner Director Chief Executive Officer

Membership No: 109752 and Managing Director

DIN - 06999772 DIN - 09588432

Alok Kumar Jagnani Brijesh Kumar

Chief Financial Officer Company Secretary

Membership No: A36070

Navi Mumbai, 23 April 2025 Navi Mumbai, 23 April 2025

 
STOCKS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z|Others

Mutual Fund A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

Registered Office : 402, Nirmal Towers, Dwarakapuri Colony, Punjagutta, Hyderabad - 500082.
SEBI Registration No's: NSE / BSE / MCX : INZ000166638. Depository Participant: IN- DP-224-2016.
AMFI Registered Number - 29900 (ARN valid upto 24th July 2025) - AMFI-Registered Mutual Fund Distributor since June 2008.
Compliance Officer :- Name: Ch.V.A. Varaprasad, Mobile No.: 9393136201, E-mail: varaprasad.challa@rlpsec.com
Grievance Cell: rlpsec_grievancecell@yahoo.com , rlpdp_grievancecell@yahoo.com
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
Copyrights @ 2014 © RLP Securities. All Right Reserved Designed, developed and content provided by